{"id":10095,"date":"2018-04-10T09:24:41","date_gmt":"2018-04-10T13:24:41","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10095"},"modified":"2018-04-10T09:24:41","modified_gmt":"2018-04-10T13:24:41","slug":"how-a-drugmaker-turned-the-abortion-pill-into-a-rare-disease-profit-machine","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10095","title":{"rendered":"How A Drugmaker Turned The Abortion Pill Into A Rare-Disease Profit Machine"},"content":{"rendered":"

(By Sarah Jane Tribble for Kaiser Health News)<\/p>\n

Even though the $550 yellow pills sold as Korlym have a controversial origin as the abortion pill, Leslie Edwin says they \u201cgave me life.\u201d<\/p>\n

The 40-year-old Georgia resident lives with Cushing\u2019s syndrome, a potentially deadly condition that causes high levels of the hormone cortisol to wreak havoc on a body. When first diagnosed, she said, she gained about 100 pounds, her blood sugars were \u201cout of control,\u201d and she suffered acne, the inability to sleep and constant anxiety. Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Sarah Jane Tribble for Kaiser Health News) Even though the $550 yellow pills sold as Korlym have a controversial<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-10095","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10095"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10095\/revisions"}],"predecessor-version":[{"id":10096,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10095\/revisions\/10096"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}